Regarding the choice of a breakpoint peptide for developing a peptide vaccine strategy in Ph+ ALL we are aware that ALL has a much more instability than CML and thus p190 has more probability to undergo mutations. Here, CNTNAP1 is linked to acute lymphoblastic leukemia.